ISTI LOGO
Towards a new dawn
×

img Acces sibility Controls

Research Projects Banner

Research Projects

Targeting nucleolin for refining anti-neoplastic chemo-immunotherapy and immunomodulation in B-Cell lymphoma

Implementing Organization

Principal Investigator
Dr Neeraj Jain
Scientist
|
CSIR-Central Drug Research Institute (CSIR-CDRI), Lucknow
CO-Principal Investigator
Dr Manisha Naithani
Scientist
|
CSIR-Central Drug Research Institute (CSIR-CDRI), Lucknow
CO-Principal Investigator
Dr Naveen Kumar Singhal
Scientist
|
CSIR-Central Drug Research Institute (CSIR-CDRI), Lucknow
CO-Principal Investigator
Dr Uttam Kumar Nath
Scientist
|
CSIR-Central Drug Research Institute (CSIR-CDRI), Lucknow
CO-Principal Investigator
Dr Gopal Chandra Kundu
Professor
|
Kalinga Institute of Industrial Technology
CO-Principal Investigator
Dr Anurag Varshey
Head
|
University of Patanjali

About

The study will understand in-depth functions of surface nucleolin in lymphoma biology, and this will determine alternative strategies to overcome chemotherapeutic resistance. The study will also analyses the importance of tumor cell specific surface nucleolin in maintaining stem cell phenotype and alternative strategies to target these cancer stem cell populations will be investigated.

Related Research

View All
Funding Organization
Funding Organization
Department of Science and Technology (DST)
Quick Information
Area of Research
Medical Sciences
Focus Area
Oncology
Start Year
2022
Sanction Amount
₹ 56.23 L
Status
Ongoing
Contact
neerajsbtjnu@gmail.com
Output
No. of Research Paper
00
Technologies (If Any)
00
No. of PhD Produced
00
No. of Patents
Filed : 00
Grant : 00
Disclaimer: Information available on this portal is sourced from various organizations and is provided for informational purposes only. Users are advised to verify details from the respective official sources.
arrowtop
Latest Updates
Loading…
Recently added across the portal